Page 3 of 10
PY7.1-9 | Renal Physiology — Part 2
Tubular Reabsorption: Getting Back What You Need
Tubular Reabsorption by Nephron Segment
| Segment | % Na+ Reabsorbed | Key Transporter | Water Permeability | Diuretic Target |
|---|---|---|---|---|
| PCT | 65-70% | Na+-K+-ATPase, SGLT2, NHE3 | Freely permeable (obligatory) | Carbonic anhydrase inhibitors (acetazolamide) |
| Thick ascending limb | 25% | NKCC2 (Na+-K+-2Cl-) | Impermeable ('diluting segment') | Loop diuretics (furosemide) |
| DCT | 5% | NCC (Na+-Cl-) | Impermeable | Thiazides (hydrochlorothiazide) |
| Collecting duct | 3-5% | ENaC | ADH-dependent (aquaporin-2) | K+-sparing (spironolactone, amiloride) |
Tubular Reabsorption by Nephron Segment
Figure: Tubular Reabsorption: Getting Back What You Need
| Segment | % Na+ Reabsorbed | Key Transporter | Water Permeability | Diuretic Target |
|---|---|---|---|---|
| PCT | 65-70% | Na+-K+-ATPase, SGLT2, NHE3 | Freely permeable (obligatory) | Carbonic anhydrase inhibitors (acetazolamide) |
| Thick ascending limb | 25% | NKCC2 (Na+-K+-2Cl-) | Impermeable ('diluting segment') | Loop diuretics (furosemide) |
| DCT | 5% | NCC (Na+-Cl-) | Impermeable | Thiazides (hydrochlorothiazide) |
| Collecting duct | 3-5% | ENaC | ADH-dependent (aquaporin-2) | K+-sparing (spironolactone, amiloride) |
Tubular Reabsorption by Nephron Segment
| Segment | % Na+ Reabsorbed | Key Transporter | Water Permeability | Diuretic Target |
|---|---|---|---|---|
| PCT | 65-70% | Na+-K+-ATPase, SGLT2, NHE3 | Freely permeable (obligatory) | Carbonic anhydrase inhibitors (acetazolamide) |
| Thick ascending limb | 25% | NKCC2 (Na+-K+-2Cl-) | Impermeable ('diluting segment') | Loop diuretics (furosemide) |
| DCT | 5% | NCC (Na+-Cl-) | Impermeable | Thiazides (hydrochlorothiazide) |
| Collecting duct | 3-5% | ENaC | ADH-dependent (aquaporin-2) | K+-sparing (spironolactone, amiloride) |
Of the 180 L filtered daily, the body excretes only 1–2 L as urine. The remaining 178–179 L is reabsorbed by the tubules. This is not passive leakage — it is a precisely regulated, segment-specific recovery operation.
Figure: Tubular Reabsorption: Getting Back What You Need
Proximal convoluted tubule (PCT) — reabsorbs ~65–70% of filtered water, Na⁺, Cl⁻, K⁺, HCO₃⁻, glucose, amino acids, phosphate, and uric acid. The PCT has a brush border (microvilli) that massively increases surface area.
Key transporters in the PCT:
- Na⁺-glucose co-transporter (SGLT2): Reabsorbs glucose with Na⁺ (secondary active transport). Glucose follows Na⁺ gradient created by Na⁺-K⁺-ATPase on the basolateral side. SGLT2 inhibitors (gliflozins) block this — used in Type 2 diabetes to increase glucose excretion.
- Na⁺-H⁺ exchanger (NHE3): Secretes H⁺ and reabsorbs Na⁺ and HCO₃⁻.
Loop of Henle — thin descending limb reabsorbs water; thick ascending limb reabsorbs Na⁺, K⁺, Cl⁻ (via NKCC2 co-transporter). Impermeable to water. Loop diuretics (furosemide) block NKCC2.
DCT and collecting duct — fine-tuning under hormonal control:
- Aldosterone (adrenal cortex): Increases Na⁺ reabsorption and K⁺ secretion via ENaC channels
- ADH (vasopressin): Inserts aquaporin-2 channels → water reabsorption in collecting duct
Transport Maximum (Tm) and Glucose Titration
Many transporters in the PCT are carrier-mediated — they can become saturated. The maximum rate at which a substance can be reabsorbed is its transport maximum (Tm).
Figure: Transport Maximum (Tm) and Glucose Titration
Glucose as the example:
- Normal plasma glucose: 70–100 mg/dL → filtrate glucose: ~100 mg/dL
- Renal threshold for glucose: ~180 mg/dL (plasma level at which glucose first appears in urine)
- Tm for glucose: ~375 mg/min (maximum reabsorptive capacity)
Below the threshold: all filtered glucose is reabsorbed, urine glucose = 0
Above the threshold but below Tm: some glucose appears in urine (glycosuria begins)
Above Tm: fixed amount reabsorbed; excess excreted proportional to plasma level
Clinical correlation: In uncontrolled diabetes, plasma glucose may reach 300–500 mg/dL. At 300 mg/dL, filtered load = 300 × 125/100 = 375 mg/min — exactly at Tm. Any higher plasma level means glycosuria. The glucose in the tubule exerts an osmotic effect — it prevents water reabsorption, causing osmotic diuresis (polyuria), which leads to dehydration and polydipsia.
Tubular secretion adds substances TO the tubular fluid from peritubular capillaries. Important secreted substances: H⁺, K⁺, organic acids (PAH, penicillin, uric acid), creatinine (small amount). Secretion of PAH is used to measure effective renal plasma flow (ERPF).
CLINICAL PEARL
Drugs like empagliflozin and dapagliflozin block SGLT2 in the PCT, preventing glucose reabsorption. This causes glycosuria even when plasma glucose is within the normal range. Clinical benefits go beyond glucose control: they reduce intraglomerular pressure (by reducing Na⁺ reabsorption → TGF feedback → afferent arteriole constriction), decrease BP, promote weight loss, and have proven cardioprotective and nephroprotective effects. They are now first-line in diabetic kidney disease — a direct therapeutic application of the physiology you are studying today.
The Counter-Current System: How the Kidney Concentrates Urine
The most elegant mechanism in renal physiology — the kidney can produce urine from 50 mOsm/kg (maximally dilute, with excess water) to 1200 mOsm/kg (maximally concentrated, with water deficit). This range allows the body to regulate plasma osmolality within ±2 mOsm/kg of 290 mOsm/kg.
Figure: The Counter-Current System: How the Kidney Concentrates Urine
The system depends on the counter-current arrangement of the loop of Henle (the multiplier) and the vasa recta (the exchanger) — and on the osmotic gradient that builds up in the medullary interstitium.
Counter-current multiplier (Loop of Henle):
- Thin descending limb: Permeable to water, impermeable to solutes. Water flows OUT into hypertonic medullary interstitium → tubular fluid becomes progressively more concentrated (hyperosmotic).
- Thick ascending limb: IMPERMEABLE to water but actively reabsorbs Na⁺, K⁺, Cl⁻ via NKCC2 → tubular fluid becomes progressively more dilute (hypoosmotic).
- Net effect: The hairpin turn allows energy spent at one segment to amplify the osmotic gradient — at the tip of the loop, interstitial osmolality reaches 1200 mOsm/kg (versus plasma at 290 mOsm/kg).
Counter-current exchanger (Vasa recta):
Blood flowing through the vasa recta would normally wash out the gradient. But the hairpin arrangement of vasa recta means solutes move OUT of descending limb and back IN to ascending limb, preserving the gradient.
Collecting duct as the final regulator:
Fluid entering the collecting duct is hypoosmotic (~100 mOsm). ADH (released when plasma osmolality rises) inserts aquaporin-2 channels → water diffuses out into the hypertonic medullary interstitium → urine is concentrated.
Without ADH (diabetes insipidus): water cannot leave the collecting duct → dilute urine 50 mOsm → large volumes (polyuria up to 15–20 L/day).
SELF-CHECK — : Concentration Mechanism
A patient with central diabetes insipidus cannot produce ADH. Which part of the counter-current system is most directly impaired?
A. Thick ascending limb NKCC2 transport
B. Aquaporin-2 insertion in the collecting duct
C. Counter-current exchange in vasa recta
D. Urea recycling in the inner medulla
Reveal Answer
Answer: B. Aquaporin-2 insertion in the collecting duct
Loop diuretics like furosemide block NKCC2 in the thick ascending limb. Aside from causing diuresis, what happens to the ability to concentrate urine?
A. Concentration is unaffected because ADH is still produced
B. Maximum urine concentration increases due to more water in the medulla
C. Medullary hyperosmotic gradient is washed out — urine cannot be concentrated
D. Concentration ability doubles because more water reaches the collecting duct
Reveal Answer
Answer: C. Medullary hyperosmotic gradient is washed out — urine cannot be concentrated